PROJ-SUN_1170x120_6-24-20

PCMA

PCMA launches new ad campaign on President Trump’s executive order to revive the so-called rebate rule

PCMA launches new ad campaign on President Trump’s executive order to revive the so-called rebate rule

WASHINGTON — The Pharmaceutical Care Management Association (PCMA) is announcing the launch of a TV and digital advertising campaign on President Trump’s Executive Order to revive the so-called rebate rule. The campaign warns policymakers and the public that the Administration’s plan will drastically increase Medicare premiums for America’s seniors and most vulnerable. Click here to view the

America’s prescription drug supply chain stands together

America’s prescription drug supply chain stands together

WASHINGTON —  On Thursday, members of the prescription drug supply and payment chain, including pharmacy benefit managers (PBMs), pharmaceutical manufacturers, pharmacies, including specialty and managed care pharmacies, and health plans, sent a letter to Vice President Mike Pence and congressional leaders affirming the safety and resiliency of the drug supply chain, and calling for public-private

PCMA adds Asher to board, Lotvin named chairman

PCMA adds Asher to board, Lotvin named chairman

WASHINGTON— The Pharmaceutical Care Management Association (PCMA) announced that Drew Asher will be joining PCMA’s board of directors. He is the chief executive officer of Envolve Pharmacy Solutions. PCMA is the national association representing America’s pharmacy benefit managers (PBMs) which administer prescription drug plans for more than 266 million Americans with health coverage through Fortune

PCMA names new staff addition to state affairs

PCMA names new staff addition to state affairs

WASHINGTON — The Pharmaceutical Care Management Association (PCMA) has announced that Regina Stivers as PCMA’s newest staff addition. Stivers joins PCMA as director, state affairs. She brings a tremendous amount of experience, having worked in both federal and state government and in the private sector overseeing economic development. Before joining PCMA, Regina served as both

New research: PBMs save $962 per person annually

New research: PBMs save $962 per person annually

WASHINGTON — Pharmacy benefit managers (PBMs) save consumers and payers an average of $962 per person per year, according to a new analysis by Visante, a $21 increase from 2016. The research also highlights PBMs’ role in reducing medication errors and improving patients’ health through increased adherence rates and specialty pharmacies. “As prescription drug prices

PCMA expands staff

PCMA expands staff

WASHINGTON — The Pharmaceutical Care Management Association (PCMA) Thursday announced staff additions to its Federal Affairs, State Affairs, Strategic Communications, and Industry Relations departments. Jocelyn Wiles has been named senior director of federal affairs. Prior to coming to PCMA, she spent five years working for America’s Essential Hospitals as a federal lobbyist. She has also worked

PCMA issues statement on proposed Rx drug rebate rule  

PCMA issues statement on proposed Rx drug rebate rule  

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott issued the following statement on the Administration’s decision to withdraw the proposed rule on prescription drug rebates: “We understand that high prescription drug prices are a burden for too many Americans. There is still a problem of affordability for consumers that

PBMs support increased transparency in prescription drug supply chain

PBMs support increased transparency in prescription drug supply chain

WASHINGTON — As the Energy and Commerce Subcommittee on Health examines ways to bring more transparency to prescription drug prices, the Pharmaceutical Care Management Association (PCMA) is confirming its principles on transparency in the prescription drug supply chain. PCMA commends the Subcommittee’s work to bring more transparency to drug prices. America’s pharmacy benefit managers (PBMs) support greater

PCMA makes statement on the administration’s Medicare Part D Rule

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer J.C. Scott issued the following statement on the Administration’s final Medicare Part D rule: “We share the administration’s goal of reducing prescription drug costs in Medicare. We are pleased with the administration’s thoughtful approach to overseeing price concessions negotiated between pharmacies and PBMs that are

PCMA issues statement on prescription drug rebate legislation

PCMA issues statement on prescription drug rebate legislation

WASHINGTON — Pharmaceutical Care Management president and chief executive officer J.C. Scott issued the following statement on newly introduced legislation by Senator Mike Braun (R, Ind.), “The Drug Price Transparency Act:” “We stand ready to work with Senator Braun and other policymakers who share the goal of reducing high drug costs. Pharmacy benefit managers (PBMs) are the

PCMA’s Merritt issues statement on drug pricing

PCMA’s Merritt issues statement on drug pricing

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer Mark Merritt released the following statement on reports of yet another round of massive price hikes by drug manufacturers. “News of recent price increases by drugmakers further confirms that the easiest way to lower costs would be for drug companies to lower their prices.” This

PCMA applauds House passage of Bill curbing opioid epidemic

PCMA applauds House passage of Bill curbing opioid epidemic

WASHINGTON — Today, the U.S. House of Representatives passed a legislative package, SUPPORT for Patients and Communities Act (H.R. 6), which requires electronic prescribing (e-prescribing) of controlled substances in Medicare. “This is an important step in the fight against America’s opioid epidemic,” the Pharmaceutical Care Management Association (PCMA) said. E-prescribing of controlled substances ensures each prescription

PCMA president Mark Merritt to leave post in December

PCMA president Mark Merritt to leave post in December

WASHINGTON — After 15 years of heading up the Pharmaceutical Care Management Association (PCMA), chief executive officer and president Mark Merritt is stepping down, effective at year-end. Under Merritt’s leadership, PCMA grew from an obscure group into the nation’s leading voice on prescription drug benefits. One of his first missions was to help shape the bill

NACDS weighs in on burdens associated with DIR fees

ARLINGTON, Va. — The “untenable” procedures around direct and indirect remuneration fees (DIR fees) can be righted with measures reducing costs for beneficiaries and the government, while promoting a more quality-driven health care system, says the National Association of Chain Drug Stores. NACDS expressed that message in comments to the Centers for Medicare & Medicaid